Tashkent hosts international conference on integrated tuberculosis control in Central Asia
Tashkent, Uzbekistan (UzDaily.com) -- On 16-17-20 September 2021, the 5th International Conference on the Comprehensive Control of Tuberculosis in Central Asia is being held in Tashkent.
This conference was organized by the Ministry of Health of the Republic of Uzbekistan and the Republican Specialized Scientific and Practical Medical Center for Phthisiology and Pulmonology (RSNPMCFiP) with the technical support of the Representative Office of the World Health Organization (WHO) in Uzbekistan and financial support from the German Development Bank KFW and the United States Agency for International Development.
Objectives of the conference:
Enabling environment and financial sustainability of tuberculosis (TB) and drug-resistant tuberculosis (DR-TB) programs to achieve the new goals of the UN General Assembly High-level Meeting on TB
Improving the detection and diagnosis of TB and DR-TB;
New opportunities to improve the effectiveness of TB and DR-TB treatment;
Participation of the community affected by tuberculosis, human rights and gender aspects;
In addition, forward-looking plans will be discussed and mapped to ensure increased political commitment and financial sustainability of national TB programs.
The conference is of strategic importance for the development of programmatic approaches and measures to improve the organization of prevention, detection, diagnosis and treatment of tuberculosis.
The Government of the Republic of Uzbekistan provides comprehensive support in the implementation of the program to combat tuberculosis. The Resolution of the President of the Republic of Uzbekistan No. 4191 of 13.02.2019 "On measures to improve the system of providing specialized tuberculosis and pulmonary care" was adopted, numerous investments were attracted from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the German Development Bank KFW, the US Agency for International Development and other international donors.
The implementation of anti-tuberculosis measures throughout the country is carried out in accordance with the "Eliminate Tuberculosis" strategy recommended by the WHO. As a result of the implementation of this strategy, TB patients have access to standard diagnostic and clinical services and receive treatment that meets international standards.
In order to improve the diagnosis of drug-resistant forms of tuberculosis, about 70 ultra-modern Xpert MTB / Rif molecular diagnostics devices have been installed in TB facilities. To ensure continuous and comprehensive treatment, TB patients are provided with quality 1st and 2nd line drugs free of charge, for the entire course of treatment. Modern short treatment regimens are being introduced using only oral new anti-tuberculosis drugs for the treatment of patients with drug-resistant tuberculosis.
The Ministry of Health of the Republic of Uzbekistan, with the support of the Government of the Republic of Uzbekistan, in cooperation with other international organizations, continues to work to improve anti-tuberculosis care for the population of the country.
Measures were taken to update and develop guidelines and regulatory documents on the following issues: introduction of modified completely oral short treatment regimens, management of children with tuberculosis, monitoring and evaluation of anti-tuberculosis measures, program management of management of patients with drug-resistant forms of tuberculosis, pharmacovigilance in the system of anti-tuberculosis care, infection control, management of latent tuberculosis infection and patients with TB / HIV co-infection and provision of psycho-social assistance for tuberculosis, as well as - intersectoral interaction in matters of migratory tuberculosis.